Humana Inc.(HUM)Stock Performance & ReturnsNYSE
Returns, drawdowns and benchmark comparison
Peer Comparison
Relative scale, growth, and profitability vs sector peers
| Ticker | Market Cap | P/E Ratio | Revenue Growth | Net Margin | EPS | ROE | Debt/Equity | Dividend Yield | 52W High | 52W Low |
|---|---|---|---|---|---|---|---|---|---|---|
HUM | 47.61 B | 37.69x | 26.20% | 0.88% | $10.52 | 6.89% | 0.76x | 0.93% | $428.88 | $163.11 |
UNH | 337.48 B | 24.29x | 0.40% | 3.14% | $15.48 | 14.15% | 0.69x | 2.45% | $458.79 | $252.96 |
ELV | 87.68 B | 17.90x | 1.40% | 2.47% | $22.59 | 11.13% | 0.69x | 1.80% | $434.35 | $270.87 |
CNC | 32.10 B | - | 4.60% | -2.83% | -$10.36 | -20.36% | 0.71x | 0.00% | $69.63 | $31.63 |
MOH | 10.17 B | 1391.57x | -5.70% | -0.02% | $0.14 | -0.16% | 0.95x | 0.00% | $244.89 | $121.06 |
Peer Valuation & Performance Analysis
Peer group analysis for Humana Inc. (HUM) compared to its primary competitors (including UNH, ELV, CNC) reveals distinct metrics. HUM trades at a valuation discount relative to its competitors, with a P/E ratio of 37.7x versus the peer average of 356.9x (representing a 89% discount). This discount might represent an undervalued entry opportunity or reflect specific risk factors the market is discounting. In terms of growth, HUM's revenue growth of 26.2% exceeds the peer average of 0.2%, highlighting its competitive strength and market share gains. Additionally, its net margin of 0.9% is comparable to the peer average of 0.7%.
Peer Performance Rankings
Ranking comparison across key performance metrics
P/E Ratio (Lower is Better)
Revenue Growth
Net Profit Margin
Financial Rankings Summary
• HUM ranks #3 in P/E ratio, #1 in revenue growth, and #3 in profit margins
• Average ranking: #2 - 🎯 Top-tier fundamentals relative to peer group
• Rankings based on actual financial data from company reports
Historical Trading Data
Price and volume data with customizable timeframes
Showing 15 of 15 trading sessions from the last 15 days
| Date | Open | High | Low | Close | Volume | Daily Change |
|---|---|---|---|---|---|---|
| 2026-10-07 | $410.00 | $410.01 | $394.81 | $396.51 | 1,827,500 | -1.92% |
| 2026-10-06 | $405.02 | $408.04 | $396.04 | $404.27 | 1,982,900 | +0.05% |
| 2026-10-05 | $389.98 | $409.17 | $385.20 | $404.07 | 1,518,900 | +4.05% |
| 2026-10-02 | $378.54 | $390.00 | $378.50 | $388.36 | 765,100 | +2.29% |
| 2026-10-01 | $380.00 | $386.86 | $376.23 | $379.68 | 891,900 | -0.50% |
| 2026-09-30 | $385.54 | $391.33 | $378.50 | $381.57 | 1,312,700 | -1.37% |
| 2026-09-29 | $386.78 | $395.23 | $385.54 | $386.87 | 1,892,600 | -0.71% |
| 2026-09-28 | $397.43 | $408.19 | $389.10 | $389.63 | 1,487,500 | -2.09% |
| 2026-09-25 | $389.70 | $413.57 | $386.71 | $397.93 | 1,938,500 | +4.63% |
| 2026-09-24 | $374.54 | $382.30 | $372.08 | $380.32 | 899,000 | +1.48% |
| 2026-09-23 | $370.00 | $377.68 | $369.13 | $374.78 | 798,600 | +0.75% |
| 2026-09-22 | $378.42 | $379.91 | $370.00 | $372.00 | 858,100 | -1.74% |
| 2026-09-21 | $386.20 | $386.67 | $374.35 | $378.58 | 925,800 | -1.98% |
| 2026-09-18 | $384.81 | $386.22 | $380.04 | $386.22 | 1,680,400 | +0.44% |
| 2026-09-17 | $386.62 | $387.83 | $380.41 | $384.52 | 850,200 | -0.05% |
Explore More Analysis for HUM
Additional research, tools, and technical breakdowns
Stock Analyzer Report
Deep-dive automated research and stock rating report.
DCF Fair Value Calculator
Discounted cash flow model and intrinsic value projection.
AI Price Predictions
Multi-scenario price predictions and consensus targets.
Insider Activity Tracker
Track buying/selling behavior of corporate insiders.
Earnings Calendar
Track upcoming and historical corporate earnings reports.
Market Insights & Research
Read the latest analysis articles and expert research.